New Schizophrenia Treatments Address Unmet Clinical Needs

P T. 2017 Feb;42(2):130-134.

Abstract

We present several novel drugs in development for enhancing cognition, treating negative symptoms, and providing improved options for treatment-resistant patients. Drug makers aim to enhance safety profiles and increase patient compliance to therapy.